PLYMOUTH MEETING, Pa., Jan. 3, 2012 /PRNewswire-USNewswire/ -- ECRI Institute (www.ecri.org), an independent nonprofit that researches the best approaches to improving patient care, listed 10 health technology issues that hospital leaders should have on their watch lists for 2012. The just-released list takes into account the convergence of critical patient safety, economic, and regulatory pressures currently facing healthcare executives.
Technology issues on this year's list span a variety of clinical and operational areas, including health IT, cardiovascular implants, minimally invasive surgical advancements, cancer therapies, and imaging and radiology services. According to the report, careful consideration of all the factors affecting whether and how to adopt these interventions will be crucial for short- and long-term strategic planning, cost-effective implementation, and optimal safety and effectiveness for patients.
"Technology is increasingly a top management concern, and is no longer confined to clinical and technical decision making. Themes emerging on our 2012 list reflect ongoing impacts of healthcare reform initiatives and new technology developments that emphasize patient-centered care," says ECRI Institute President and CEO Jeffrey C. Lerner, PhD.
"This list addresses safety improvements, interconnectedness of technology, personalized medicine tailored to individual care characteristics and preferences, and increasing cost pressures," adds Lerner.
ECRI Institute's new report, Top 10 C-Suite Watch List: Hospital Technology Issues for 2012, available for
SOURCE ECRI Institute
Copyright©2010 PR Newswire.
All rights reserved
Related medicine technology :
1. Austen BioInnovation Institute and Lubrizol Announce New Strategic Innovation Partnership
2. Life Sciences Startup PhotOral Licenses Patented Oral Blue-Light Technology From Forsyth Institute
3. FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices
4. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
5. SRI International Awarded Contract Worth Up to $100M From National Institute of Allergy and Infectious Diseases
6. Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging
7. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
8. The Food and Drug Law Institute to Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf
9. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
10. Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
11. Russian Institute of Nutrition-Nutrilite Health Institute Collaboration Identifies Stress Markers Potentially Linked to Chronic Diseases in Overweight Russian Adults